Skip to main content
OpenTrials
Completed

NCT Number: NCT01784497

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Health Related Quality of Life Assessment In Egyptian Recipients After Living Donor Liver Transplantation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ain Shams Center For Organ Transplantation (ASCOT),Ain Shams university

Cairo, Egypt

About this study

This Study Aims to Evaluate:-

  • Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.
  • Impact of post transplant medical and psychiatric complications on quality of life

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult Egyptian patients
  • 18-60 years old
  • Patients transplanted for HCV related disease and /or HCC
  • Informed consent

Exclusion criteria

  • Other etiologies for end stage liver disease (such as HBV and cholestatic liver disease and autoimmune hepatitis).

Treatment and study plan

Primary outcomes

  1. Quality of life after LDLT In Egyptian patients using short form 36 (SF - 36) score.

    Time frame: 6 months

Secondary outcomes

  1. Impact of post transplant medical and psychiatric complications on quality of life

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Feb 6, 2013
Registry last updated
Oct 15, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.